These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3471865)

  • 1. Absence of biochemical heterogeneity in McArdle's disease. A high resolution SDS-polyacrylamide gel electrophoresis study.
    Mantle D; Lauffart B; Atack J; Lane RJ
    J Neurol Sci; 1987 Mar; 78(1):63-70. PubMed ID: 3471865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. McArdle's disease: a study on the molecular basis of two different etiologies of myophosphorylase deficiency.
    Koster JF; Slee RG; Jennekens FG; Wintzen AR; van Berkel TJ
    Clin Chim Acta; 1979 Jun; 94(3):229-35. PubMed ID: 111879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myophosphorylase deficiency: two different molecular etiologies.
    Feit H; Brooke MH
    Neurology; 1976 Oct; 26(10):963-7. PubMed ID: 1066528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histochemical and biochemical studies in a patient with myophosphorylase deficiency.
    Tachi N; Sasaki K; Tachi M; Sugie H
    Eur Neurol; 1990; 30(1):52-5. PubMed ID: 2298228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new variant of late-onset myophosphorylase deficiency.
    Kost GJ; Verity MA
    Muscle Nerve; 1980; 3(3):195-201. PubMed ID: 6929403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. McArdle's disease presenting as treatment resistant polymyositis.
    Higgs JB; Blaivas M; Albers JW
    J Rheumatol; 1989 Dec; 16(12):1588-91. PubMed ID: 2625691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research on molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). Use of new protein mapping and immunological techniques.
    Daegelen-Proux D; Kahn A; Marie J; Dreyfus JC
    Ann Hum Genet; 1981 May; 45(2):113-20. PubMed ID: 6797345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. McArdle's disease--what limit to the age of onset?
    Hewlett RH; Gardner-Thorpe C
    S Afr Med J; 1978 Jan; 53(2):60-3. PubMed ID: 273990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral nerve and vasculature involvement in myophosphorylase deficiency (McArdle's disease).
    Byard RW; Lach B; Preston DN
    Pathology; 1991 Jan; 23(1):62-5. PubMed ID: 2062570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset Mcardle's disease with unusual electromyographic findings.
    Pourmand R; Sanders DB; Corwin HM
    Arch Neurol; 1983 Jun; 40(6):374-7. PubMed ID: 6573876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. McArdle's disease with late-onset symptoms: case report and review of the literature.
    Felice KJ; Schneebaum AB; Jones HR
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):407-8. PubMed ID: 1602316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of glycogen phosphorylase isoenzymes present in cultured skeletal muscle from patients with McArdle's disease.
    Sato K; Imai F; Hatayama I; Roelofs RI
    Biochem Biophys Res Commun; 1977 Sep; 78(2):663-8. PubMed ID: 269730
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease).
    Tsujino S; Shanske S; DiMauro S
    N Engl J Med; 1993 Jul; 329(4):241-5. PubMed ID: 8316268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early onset myophosphorylase deficiency (Mc Ardle's disease) with absence of myophosphorylase protein on SDS electrophoresis. The role of the ischemic forearm test.
    van Riet W; de Meirsman J; de Saedeleer J; Dom R; Carton H; van den Heede J; Bulcke JA
    Clin Neurol Neurosurg; 1985; 87(2):85-90. PubMed ID: 3861283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angina in McArdle's disease.
    Nicholls DP; Campbell NP; Stevenson HP; Patterson VH
    Heart; 1996 Oct; 76(4):372-3. PubMed ID: 8983689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low muscle levels of pyridoxine in McArdle's syndrome.
    Haller RG; Dempsey WB; Feit H; Cook JD; Knochel JP
    Am J Med; 1983 Feb; 74(2):217-20. PubMed ID: 6572033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of muscle-type phosphorylase in innervated and aneural cultured muscle of patients with myophosphorylase deficiency.
    Martinuzzi A; Vergani L; Carrozzo R; Fanin M; Bartoloni L; Angelini C; Askanas V; Engel WK
    J Clin Invest; 1993 Oct; 92(4):1774-80. PubMed ID: 8408630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective atrophy of type 1 muscle fibers in McArdle's disease.
    Felice KJ; Grunnet ML; Sima AA
    Neurology; 1996 Aug; 47(2):581-3. PubMed ID: 8757045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. McArdle's disease: biochemical and molecular genetic studies.
    Servidei S; Shanske S; Zeviani M; Lebo R; Fletterick R; DiMauro S
    Ann Neurol; 1988 Dec; 24(6):774-81. PubMed ID: 3207360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nonsense mutation in the myophosphorylase gene in a Japanese family with McArdle's disease.
    Bruno C; Tamburino L; Kawashima N; Andreu AL; Shanske S; Hadjigeorgiou GM; Kawashima A; DiMauro S
    Neuromuscul Disord; 1999 Jan; 9(1):34-7. PubMed ID: 10063833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.